How to consume Zybiraa 250mg tablet?

Zybiraa 250mg tablet is taken orally every day without food. The doctor decides whether to take it once or twice. The medicine should be taken one hour before or two hours after the meal.

Is it safe to drive after taking Zybiraa 250mg tablet?

It is advisable to avoid driving and operating heavy machinery as Zybiraa may cause dizziness.

Is it safe to take Zybiraa 250mg tablet during pregnancy or breastfeeding?

Zybiraa 250mg tablet is a medication for treating prostate cancer in men. Therefore female patients should avoid taking this medicine in case of pregnancy and breastfeeding.

What are the precautions to be followed for storing Zybiraa 250mg tablet?

It is advisable to store the Zybiraa 250mg tablets at room temperature at a place below 30°C.

Deal of the Day — limited-time pharmacy picks!Deal of the Day — today's spotlight pharmacy prices, refreshed daily.

Zybiraa 250Mg Tablet

Name: Zybiraa 250Mg Tablet
Brand: zybiraa
Price: 8805 INR
Availability: InStock
Rating: 4.71 (7 reviews)

Rx Required

Salt Composition: Abiraterone acetate

Expiry Date: 01/2028

Price on Request

Inclusive of all taxes

▼

120 Tablet in Bottle

About The Product

Prostate Cancer

Zybiraa 250Mg Tablet is a hormonal therapy based anticancer medicine used to treat prostate cancer in men. Abiraterone acetate is the generic name of the medicine. It is an anti-androgen medicine which work by blocking the production of male hormone androgen to slow down the progression of cancer. It is only meant for treating prostate cancer in men and should not be prescribed to women. It also contains lactose and sodium, so inform your physician if you are lactose intolerant or on a salt control diet.

Side Effects

Side effects are undesirable symptoms that can result from any medical treatment.
Like any other medicine, Zybiraa 250Mg Tablet also causes some adverse impact on the body, most of which resolve without any medical attention.
Some common side effects include: Groin pain Irregular heart rate Blood in urine Yellowing of skin and eyes Bleeding Unusual bruising Swelling of joints Diarrhea Constipation Trouble sleeping Heartburn Hot flashes Contact your doctor immediately if you experience any severe or unusual side effects.

Safety Advice

Alcohol

The interaction of alcohol with this drug is still unknown. It is advisable not to consume alcohol while taking Zybiraa 250Mg Tablet.

Pregnancy

Do not take Zybiraa 250Mg Tablet during pregnancy, as it is a highly unsafe medicine for the fetus. Also, this medicine is especially designed to treat male-related cancers.

Breast Feeding

Zybiraa 250Mg Tablet is unsafe to use during breastfeeding as it may cause toxicity to the baby. Also, this medicine is especially designed to treat male-related cancers.

Driving

Zybiraa 250Mg Tablet may cause side effects such as dizziness or lack of concentration, which could affect your ability to drive. So it's better to avoid driving or operating heavy machinery.

Kidney

Consumption of Zybiraa 250Mg Tablet should be avoided without informing the doctor if you have any kidney-related issues

Liver

Consumption of Zybiraa 250Mg Tablet should be avoided without informing the doctor if you have any liver-related issues.

FAQs

Zybiraa 250mg tablet is an anticancer tablet that is used in the treatment of prostate cancer in men.

Reference

1.Kumar, S., Joshi, A., Takke, A., Varghese, D., Pathak, S., Noronha, V., ... & Gota, V. (2025).

Comparison of PSA Response to Generic Versus Innovator (Zytiga) Formulations of Abiraterone in Metastatic CRPC: A Retrospective Analysis.

Indian Journal of Medical and Paediatric Oncology. 2.

Rehman, Y., & Rosenberg, J. E.

(2012). Abiraterone acetate: oral androgen biosynthesis inhibitor for treatment of castration-resistant prostate cancer.

Drug design, development and therapy, 13-18. 3.Scott, L.

J. (2017).

Abiraterone acetate: a review in metastatic castration-resistant prostrate cancer. Drugs, 77(14), 1565-1576.

4. Buikin, P., Vologzhanina, A., Novikov, R., Dorovatovskii, P., & Korlyukov, A.

(2023). Abiraterone Acetate Complexes with Biometals: Synthesis, Characterization in Solid and Solution, and the Nature of Chemical Bonding.

Pharmaceutics, 15(9), 2180. 5.

Salem, M., & Garcia, J. A.

(2011). Abiraterone acetate, a novel adrenal inhibitor in metastatic castration-resistant prostate cancer.

Current oncology reports, 13(2), 92-96.

Certified Content

Written By

Venika Choudhary

Medical Content Writer @ Magicine Pharma

Reviewed By

Dr. Aditya Sarin

MBBS, MD - General Medicine, DrNB - Medical Oncology | 11 Years Experience

Check Our Editorial Policy

Last updated: 18 Sept 2026 | 04:21 PM (IST)

Trust & safety

Medical Disclaimer

Accurate, reviewed information to support informed healthcare decisions

For informational purposes only

Not a substitute for professional medical advice

Consult your doctor for diagnosis and treatment

Magicine's primary objective is to ensure that its customers receive accurate, genuine, and trustworthy information reviewed by medical experts.

The content on this website has been produced solely for informational purposes. This is not intended to take the place of medical advice and care provided by a licensed professional, though.

This information may not include all potential side effects, warnings, and details about specific lab tests, medications, and medical conditions. Please ask your doctor any questions you may have about any drug or disease.

Our goal is not to replace or substitute for the doctor-patient relationship, but to uphold and strengthen it.

Always follow advice from your doctor, pharmacist, or other licensed healthcare professional before starting, stopping, or changing any medicine or treatment.

Read full medical disclaimer in Terms & Conditions